Search Results - "Shojo, Kazunori"
-
1
The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
Published in Cancer science (01-03-2021)“…This study aimed to clarify the clinical characteristics and oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) who developed…”
Get full text
Journal Article -
2
Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer
Published in Journal for immunotherapy of cancer (01-03-2022)“…BackgroundThe aims of this study were (1) to clarify the impact of tertiary lymphoid structure (TLS) status on the outcome and immunogenomic profile of human…”
Get full text
Journal Article -
3
Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study
Published in Urologic oncology (01-03-2022)“…•We compared the clinical outcomes of clinically node-positive UTUC patients who were treated by NAC followed by RNU or upfront RNU followed by…”
Get full text
Journal Article -
4
A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
Published in BMC medical genomics (09-10-2021)“…Ductal adenocarcinoma and neuroendocrine cancer are rare subtypes of prostate cancer with poor prognosis and limited therapeutic options. We present the first…”
Get full text
Journal Article -
5
First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion
Published in IJU case reports (01-05-2021)“…Introduction Ductal adenocarcinoma of the prostate is a rare prostate cancer variant and associated with higher stage and greater risk of mortality. Optimal…”
Get full text
Journal Article -
6
Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins
Published in Laboratory investigation (01-10-2024)“…Targeting novel inhibitory ligands beyond anti-PD-1 and PD-L1 and CTLA-4 therapies is essential for the next decade of the immunotherapy era. Agents for the B7…”
Get full text
Journal Article -
7
Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching
Published in Annals of surgical oncology (01-10-2019)“…Background This study aimed to investigate the long-term oncologic outcomes of laparoscopic radical nephroureterectomy (LRNU) and open radical…”
Get full text
Journal Article -
8
Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma
Published in World journal of urology (26-03-2024)“…Purpose The diagnostic accuracy of computed tomography urography for upper tract urothelial carcinoma is high; however, difficulties are associated with…”
Get full text
Journal Article -
9
The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy
Published in Urologic oncology (01-09-2019)“…•The transition zone (TZ) origin prostate cancer had more favorable pathological characteristics.•The Tz origin prostate cancer had better oncological…”
Get full text
Journal Article -
10
PD15-06 IMPACT OF TUMOR LOCATION ON BIOCHEMICAL RECURRENCE OF PT3 PROSTATE CANCER
Published in The Journal of urology (01-04-2017)Get full text
Journal Article -
11
A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma
Published in European urology oncology (01-12-2020)“…The current guideline lacks evidence for creating individualized surveillance strategies for upper tract urothelial carcinoma (UTUC) patients after radical…”
Get full text
Journal Article -
12
First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion
Published in IJU case reports (01-05-2021)“…INTRODUCTIONDuctal adenocarcinoma of the prostate is a rare prostate cancer variant and associated with higher stage and greater risk of mortality. Optimal…”
Get full text
Report